Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727397
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2023-01-10
Brief Title:
Efficacy and Safety of RC28-E Versus Aflibercept
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Wet Age-related Macular Degeneration |
Keywords: